<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE ep-patent-document PUBLIC "-//EPO//EP PATENT DOCUMENT 1.4//EN" "ep-patent-document-v1-4.dtd"><ep-patent-document id="EP0800405A1" file="EP95943474NWA1.xml" lang="en" doc-number="0800405" date-publ="19971015" kind="A1" country="EP" status="n" dtd-version="ep-patent-document-v1-4"><SDOBI lang="en"><B000><eptags><B001EP>ATBECHDEDKESFRGBGRITLILUNLSEMCPTIE..................................................................</B001EP><B003EP>*</B003EP><B007EP>EPregister to ST.36 EBD process v 1.0 kbaumeister@epo.org (15 Jan 2013)</B007EP></eptags></B000><B100><B110>0800405</B110><B130>A1</B130><B140><date>19971015</date></B140><B190>EP</B190></B100><B200><B210>95943474.0</B210><B220><date>19951219</date></B220><B240><B241><date>19970702</date></B241></B240><B250>en</B250><B251EP>en</B251EP><B260>en</B260></B200><B300><B310>19940359293</B310><B320><date>19941219</date></B320><B330><ctry>US</ctry></B330></B300><B400><B405><date>19971015</date><bnum>199742</bnum></B405><B430><date>19971015</date><bnum>199742</bnum></B430></B400><B500><B510EP><classification-ipcr sequence="1"><text>A61K  47/    30            A I                    </text></classification-ipcr><classification-ipcr sequence="2"><text>A61K  38/    22            A I                    </text></classification-ipcr><classification-ipcr sequence="3"><text>A61K  38/    29            A I                    </text></classification-ipcr><classification-ipcr sequence="4"><text>A61P   3/    00            A I                    </text></classification-ipcr><classification-ipcr sequence="5"><text>A61P  43/    00            A I                    </text></classification-ipcr><classification-ipcr sequence="6"><text>C07K  14/   635            A I                    </text></classification-ipcr><classification-ipcr sequence="7"><text>A61K  38/    00            A N                    </text></classification-ipcr></B510EP><B540><B541>en</B541><B542>CONTINUOUS LOW-DOSE ADMINISTRATION OF PARATHYROID HORMONE OR ITS AGONIST</B542><B541>fr</B541><B542>ADMINISTRATION EN CONTINU DE FAIBLES DOSES D'HORMONE PARATHYRO DIENNE OU DE SON AGONISTE</B542><B541>de</B541><B542>KONTINUIERLICHE NIEDRIGDOSIERTE VERABREICHUNG VON PARATHYROIDHORMON ODER DEREN AGONIST</B542></B540></B500><B700><B710><B711><snm>Beth Israel Hospital Association</snm><adr><str>330 Brookline Avenue</str><city>Boston, Massachusetts 02215</city><ctry>US</ctry></adr></B711></B710><B720><B721><snm>CHOREV, Michael</snm><adr><str>Apt. 3, 1757 Beacon Street</str><city>Brooline, MA 02146</city><ctry>US</ctry></adr></B721><B721><snm>ROSENBLATT, Michael</snm><adr><str>130 Lake Avenue</str><city>Newton Centre, MA 02159</city><ctry>US</ctry></adr></B721></B720><B740><B741><snm>Lunt, Mark George Francis</snm><adr><str>Dibb Lupton Alsop Fountain Precinct Balm Green</str><city>Sheffield S1 1RZ</city><ctry>GB</ctry></adr></B741></B740></B700><B800><B840><ctry>AT</ctry><ctry>BE</ctry><ctry>CH</ctry><ctry>DE</ctry><ctry>DK</ctry><ctry>ES</ctry><ctry>FR</ctry><ctry>GB</ctry><ctry>GR</ctry><ctry>IE</ctry><ctry>IT</ctry><ctry>LI</ctry><ctry>LU</ctry><ctry>MC</ctry><ctry>NL</ctry><ctry>PT</ctry><ctry>SE</ctry></B840><B860><B861><dnum><anum>US1995016554</anum></dnum><date>19951219</date></B861><B862>en</B862></B860><B870><B871><dnum><pnum>WO1996019246</pnum></dnum><date>19960627</date><bnum>199629</bnum></B871></B870></B800></SDOBI></ep-patent-document>